JPMorgan Chase & Co. Reiterates “GBX 9,000” Price Target for Reckitt Benckiser Group (LON:RB)
Reckitt Benckiser Group (LON:RB) received a GBX 9,000 ($117.60) price objective from JPMorgan Chase & Co. in a research note issued on Thursday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 36.47% from the stock’s previous close.
A number of other equities analysts also recently commented on the stock. UBS Group downgraded shares of Telstra from a “buy” rating to a “neutral” rating in a research note on Monday, July 1st. Goldman Sachs Group set a GBX 6,870 ($89.77) target price on shares of Reckitt Benckiser Group and gave the company a “neutral” rating in a research note on Tuesday, June 25th. Deutsche Bank reissued a “hold” rating and issued a GBX 1,775 ($23.19) target price on shares of in a research note on Wednesday, June 26th. Royal Bank of Canada downgraded shares of 3M from an “outperform” rating to a “sector perform” rating and dropped their price target for the stock from $207.00 to $176.00 in a research note on Monday, July 8th. Finally, Liberum Capital lifted their price target on shares of Moneysupermarket.Com Group from GBX 520 ($6.79) and gave the stock a “buy” rating in a research note on Thursday. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and twelve have issued a buy rating to the company’s stock. Reckitt Benckiser Group currently has an average rating of “Hold” and a consensus price target of GBX 7,211.11 ($94.23).
Shares of RB stock opened at GBX 6,595 ($86.18) on Thursday. The company has a fifty day simple moving average of GBX 6,384.22. Reckitt Benckiser Group has a 52 week low of GBX 5,559 ($72.64) and a 52 week high of GBX 7,174 ($93.74). The company has a debt-to-equity ratio of 80.49, a quick ratio of 0.47 and a current ratio of 0.65. The stock has a market cap of $46.76 billion and a P/E ratio of 21.64.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Article: What are economic reports?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.